MONOCLONAL ANTIBODIES DIRECTED TO PHOSPHORYLATED PSD95 AND USES THEREOF Read more about MONOCLONAL ANTIBODIES DIRECTED TO PHOSPHORYLATED PSD95 AND USES THEREOF US Application 63/426,275Filed on 2022-11-17
ISLET AMYLOID POLYPEPTIDE ISOFORMS AND PEPTIDES AND METHODS OF USE Read more about ISLET AMYLOID POLYPEPTIDE ISOFORMS AND PEPTIDES AND METHODS OF USE US Application 63/417,582Filed on 2022-10-19
HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE Read more about HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE US Application 63/397,235Filed on 2022-08-11
MONOCLONAL ANTIBODIES DIRECTED TO THREONINE PHOSPHORYLATION OF PSD95 AND USES THEREOF Read more about MONOCLONAL ANTIBODIES DIRECTED TO THREONINE PHOSPHORYLATION OF PSD95 AND USES THEREOF US Application 63/358,178Filed on 2022-07-04
COMPOUNDS AND MOLECULAR TARGETS FOR TREATING AND/OR PREVENTING ALZHEIMER'S DISEASE Read more about COMPOUNDS AND MOLECULAR TARGETS FOR TREATING AND/OR PREVENTING ALZHEIMER'S DISEASE US Application 63/253,992Filed on 2021-10-08
PHENOTYPIC AGE AND DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY Read more about PHENOTYPIC AGE AND DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY US Application 62/618,422Filed on 2018-01-17
HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE Read more about HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE US Application 63/178,083Filed on 2021-04-22
INHIBITORS OF LRP1-DKK PROTEIN COMPLEX TO PROMOTE CLEARANCE OF AMYLOID-BETA Read more about INHIBITORS OF LRP1-DKK PROTEIN COMPLEX TO PROMOTE CLEARANCE OF AMYLOID-BETA US Application 63/033,579Filed on 2020-06-02
GINGERENONE A PRO-DRUGS AS SENOTHERAPEUTICS AND METHODS OF USE Read more about GINGERENONE A PRO-DRUGS AS SENOTHERAPEUTICS AND METHODS OF USE US Application 63/302,873Filed on 2022-01-25
INHIBITORS OF LRP1-DKK PROTEIN COMPLEX TO PROMOTE CLEARANCE OF AMYLOID-BETA Read more about INHIBITORS OF LRP1-DKK PROTEIN COMPLEX TO PROMOTE CLEARANCE OF AMYLOID-BETA US Application 62/857,204Filed on 2019-06-04